Purple Biotech Ltd
PPBT
$2.60
-$0.0518-1.96%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Net Income | -410.00K | -2.41M | -4.83M | -5.04M | |
| Total Depreciation and Amortization | 40.00K | 49.00K | 48.00K | 50.00K | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -640.00K | -767.00K | -1.26M | -262.00K | |
| Change in Net Operating Assets | -1.00M | -853.00K | 1.06M | 1.59M | |
| Cash from Operations | -2.01M | -3.98M | -4.98M | -3.66M | |
| Capital Expenditure | -- | -- | 0.00 | 1.00K | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | 0.00 | 0.00 | |
| Divestitures | -- | -- | -- | -- | |
| Other Investing Activities | 38.00K | 87.00K | 74.00K | 1.01M | |
| Cash from Investing | 38.00K | 87.00K | 74.00K | 1.01M | |
| Total Debt Issued | -- | -- | -- | -- | |
| Total Debt Repaid | -48.00K | -46.00K | -42.00K | -42.00K | |
| Issuance of Common Stock | 4.37M | 564.00K | 4.00K | 678.00K | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -380.00K | -85.00K | 4.28M | -64.00K | |
| Cash from Financing | 3.94M | 433.00K | 4.25M | 572.00K | |
| Foreign Exchange rate Adjustments | 0.00 | -5.00K | 47.00K | -20.00K | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | 1.96M | -3.46M | -615.00K | -2.10M | |